Page last updated: 2024-09-03

technetium tc 99m hydroxymethylene diphosphonate and Low Bone Density

technetium tc 99m hydroxymethylene diphosphonate has been researched along with Low Bone Density in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's5 (83.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamamoto, I1
Alvarez, L; de Osaba, MJ; Guañabens, N; Monegal, A; Parés, A; Peris, P; Pons, F; Roca, M; Rodés, J; Torra, M1
Bohuslavizki, KH; Brenner, W; Clausen, M; Henze, E; Sieweke, N; Tinnemeyer, S1
Antón, A; Caballero, O; Martínez, A; Serrano, J; Verdú, J1
Achong, DM; Mahoney, J1
Hasling, C; Mosekilde, L; Tågehøj Jensen, F; Tågehøj Jensen, PC1

Reviews

1 review(s) available for technetium tc 99m hydroxymethylene diphosphonate and Low Bone Density

ArticleYear
[Skeletal nuclear medicine].
    Kaku igaku. The Japanese journal of nuclear medicine, 1995, Volume: 32, Issue:5

    Topics: Absorptiometry, Photon; Biomarkers; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Neoplasms; Female; Humans; Male; Technetium Tc 99m Medronate; Tomography, Emission-Computed, Single-Photon

1995

Trials

1 trial(s) available for technetium tc 99m hydroxymethylene diphosphonate and Low Bone Density

ArticleYear
Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years.
    Gastroenterology, 1997, Volume: 113, Issue:1

    Topics: Absorptiometry, Photon; Bone Density; Bone Diseases, Metabolic; Drug Administration Schedule; Etidronic Acid; Female; Femur; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Lumbar Vertebrae; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sodium Fluoride; Technetium Tc 99m Medronate; Time Factors

1997

Other Studies

4 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Low Bone Density

ArticleYear
Quantification of diphosphonate uptake based on conventional bone scanning.
    European journal of nuclear medicine, 1997, Volume: 24, Issue:10

    Topics: Adult; Aged; Bone and Bones; Bone Diseases, Metabolic; Case-Control Studies; Female; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tissue Distribution

1997
[Reversible hyperparathyroid metabolic osteopathy secondary to parathyroid carcinoma].
    Revista espanola de medicina nuclear, 1998, Volume: 17, Issue:1

    Topics: Bone and Bones; Bone Diseases, Metabolic; Carcinoma; Contrast Media; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Time Factors

1998
Demonstration of increased bone metabolism in melorheostosis by multiphase bone scanning.
    Clinical nuclear medicine, 1991, Volume: 16, Issue:11

    Topics: Adult; Bone Diseases, Metabolic; Female; Femur; Humans; Melorheostosis; Patella; Radionuclide Imaging; Technetium Tc 99m Medronate; Tibia

1991
Bisphosphonate whole body retention test: relations to bone mineralization rate, renal function and bone mineral content in osteoporosis and metabolic bone disorders.
    European journal of clinical investigation, 1987, Volume: 17, Issue:6

    Topics: Adult; Aged; Bone and Bones; Bone Diseases, Metabolic; Female; Humans; Kidney; Male; Middle Aged; Minerals; Osteoporosis; Regression Analysis; Technetium Tc 99m Medronate

1987